We analyzed the in¯uence of presenilins on the genetic cascades that control neuronal differentiation in Xenopus embryos. Resembling sonic hedgehog (shh) overexpression, presenilin mRNA injection reduced the number of N-tubulin 1 primary neurons and modulated Gli3 and Zic2 according to their roles in activating and repressing primary neurogenesis, respectively. Presenilin increased shh expression within its normal domain, mainly in the¯oor plate, whereas an antisense X-presenilin-a morpholino oligonucleotide reduced shh expression. Both shh and presenilin promoted cell proliferation and apoptosis, but the effects of shh were widely distributed, while those resulting from presenilin injection coincided with the range of shh signaling. We suggest that presenilin may modulate primary neurogenesis, proliferation, and apoptosis in the neural plate, through the enhancement of shh signaling. q
The most common forms of familial Alzheimer's disease (AD) are associated to mutations in the amyloid precursor protein (APP), presenilin-1 (Ps1), and presenilin-2 (Ps2) genes (Selkoe, 1999) . APP is cleaved by a series of secretases, and a critical event in the pathogenesis of AD occurs when an altered g-secretase activity overproduces the 42 amino acid isoform of the amyloid-b peptide, which accumulates in the cerebral cortex as an early and invariant marker of the disease. Deletion of Ps1 greatly reduces gsecretase activity in mice (De Strooper et al., 1998) , and recent evidences indicated that presenilins may contain the active site (Li et al., 2000) .
Presenilins are polytopic membrane proteins located in the endoplasmic reticulum, Golgi complex, plasma membrane, and nuclear envelope (Cook et al., 1996; Kovacs et al., 1996; Walter et al., 1996; De Strooper et al., 1997) . Ps1 and Ps2 genes encode 46-and 55-kDa proteins, respectively, about 80% homologous, with eight transmembrane domains and a large hydrophilic loop facing to the cytoplasm (Mattson et al., 1998) . They undergo endoproteolysis within the loop domain, and the resultant 30-kDa N-terminal and 20-kDa C-terminal fragments combine into stable 1:1 heterodimers that may constitute the biologically active form (Capell et al., 1998) .
In addition to their role in APP proteolysis, presenilins have been proposed to modulate programmed cell death (PCD) (Deng et al., 1996; Kim et al., 1997; Loetscher et al., 1997; Roperch et al., 1998; Passer et al., 1999; , intracellular calcium homeostasis (Buxbaum et al., 1998; Stabler et al., 1999) , the cell response to protein misfolding in the endoplasmic reticulum (Niwa et al., 1999) , and the Wnt/b -catenin pathway Levesque et al., 1999; Nishimura et al., 1999) . Most of these functions have been studied in cultured cells and remain to be tested in vivo to determine their functional relevance.
Apart from the involvement of mutant presenilins in the pathogenesis of AD, most of what we know about the physiological role of presenilins has derived from the analysis of null phenotypes in Caenorhabditis elegans, Drosophila melanogaster, and mice. The emerging picture shows that they are central to neuronal differentiation. Evidences include the loss of neural progenitor cells and neurons from brains of Ps1 null mice (Shen et al., 1997) , disorganization of the trunk ventral neural tube in mice lacking both Ps1 and Ps2 (Donoviel et al., 1999) and the neurogenic phenotypes in Drosophila presenilin mutants . This role for presenilins is supported by their high levels of expression during periods of neurogenesis and their predominant location in the adult central nervous system (Berezovska et al., 1997; Shen et al., 1997; Mattson et al., 1998) . However, despite studies concerning their facilitation of Notch signaling (De Strooper et al., 1999; Song et al., 1999; Struhl and Greenwald, 1999; Handler et al., 2000) , the ability of presenilins to regulate different steps of the genetic cascades involved in neuronal differentiation has not been extensively explored. Therefore, we decided to focus on this subject using the Xenopus primary neurogenesis cascade as a well-established model of neuronal differentiation.
Two Xenopus homologues of human Ps1 and Ps2 have been isolated. The encoded proteins, X-Ps-a and X-Ps-b , are 89.4 and 85.9% similar to Ps1 and Ps2, respectively. Competitive reverse transcriptase-polymerase chain reaction (RT-PCR) revealed high levels of both transcripts in the oocyte, which decreased during early development, and zygotic expression became evident at tailbud stages (Tsujimura et al., 1997) .
Amphibian neurogenesis comprises two distinct waves of differentiation. Primary neurogenesis produces a simple network that mediates swimming and escape re¯exes in the early tadpole and secondary neurogenesis further generates neurons involved in more complex behaviors of the late tadpole. In Xenopus, the ®rst wave results in three stripes expressing the terminal neuronal differentiation marker Ntubulin arranged at both sides of the neural plate, containing primary motor neurons, interneurons, and sensory neurons, separately (Chitnis et al., 1995) . This process is early controlled by the balanced expression of prepattern genes. Amongst them are members of the Gli and Zic family of zinc ®nger transcription factors (Lee et al., 1997; Marine et al., 1997; Brewster et al., 1998; Nakata et al., 1998) . Within the neural plate, Gli3 is expressed in a graded fashion with highest levels in lateral regions and Zic2 transcripts are arranged in stripes that alternate with those in which primary neuron formation takes place. While Gli3 promotes neuronal differentiation, Zic2 suppresses it. By exerting opposite functions, prepattern genes outline the sites where primary neuron formation will be permitted or excluded. Prepattern genes, in turn, regulate the more re®ned expression of proneural genes, a group of basic helix±loop±helix transcription factors such as X-ngnr-1 and Xash-3 (Zimmerman et al., 1993; Ma et al., 1996) . Thus, proneural genes confer competence to neural cells of becoming differentiated neurons to more restricted domains. Within the proneural cluster, one cell is singled out to develop into a neuronal precursor, while the neighbors are prevented from doing so. This process of lateral inhibition is mediated by the neurogenic gene Notch and its membrane-bound ligand Delta (Chitnis et al., 1995) . Proneural genes promote the expression of Delta in the selected cell (Ma et al., 1996) . Then, Delta interacts with the receptor Notch on the surface of the neighboring cell. The receptor is cleaved to render the intracellular domain (Notch ICD ) that enters the nucleus and, in association with CSL intracellular transducers, activates the transcription of target genes of the HES family that, acting as transcriptional repressors, lead to suppression of neuronal fate (Wettstein et al., 1997; Bray, 1998) .
Several evidences indicate that presenilins facilitate the Notch signaling pathway. From experiments with Drosophila mutants, it has been proposed that presenilin is required for activity and nuclear access of Notch (Struhl and Greenwald, 1999) . Moreover, in vitro studies on mammalian cells have shown evidences that a Ps1-dependent g-secretase-like activity mediates the intramembranous cleavage of the mature receptor to release Notch ICD (De Strooper et al., 1999) . However, the Notch signaling pathway has been shown to remain partially activated even when the g-secretase-like activity is blocked (Berezovska et al., 2000) and Ps1 point mutations were able to separate APP proteolysis from Notch processing (Kulic et al., 2000) . Other authors favor the idea that presenilins are required before Notch ICD release, during the maturation of the receptor , or in the secretory pathway .
Hedgehog proteins comprise a family of secreted molecules essential for patterning a variety of structures during animal embryogenesis (Lee et al., 1992; Riddle et al., 1993; Echelard et al., 1993; Krauss et al., 1993; Ekker et al., 1995) . One of them, sonic hedgehog (shh), is expressed by the notochord and the¯oor plate in vertebrates. Either oor plate cells or ventral neurons can be induced in vitro by Shh protein in a concentration-dependent way (Roelink et al., 1995) , indicating a role for shh signaling during patterning of the neural tube. It has been proposed that HNF-3b , a transcription factor of the winged-helix family, activates shh transcription in the notochord. Then, secreted Shh from the notochord activates Gli1 in the midline of the neural plate. Gli1, in turn, switches on HNF-3b which, ultimately, activates shh expression in¯oor plate cells. Finally, shh signaling from the¯oor plate induces motor neurons in adjacent cells of the ventral neural tube (Lee et al., 1997) .
We have previously found in Xenopus embryos that retinoid and hedgehog signaling modulated primary neurogenesis by counterbalancing the expression of prepattern genes with opposite functions. While Xenopus shh (X-shh) negatively regulated genes that promote the neurogenesis cascade, retinoids favored neurogenesis by repressing X-shh expression. Moreover, shh signaling may promote proliferation of neural precursors for later differentiation of secondary ventral neurons at the expense of primary neuron formation (Franco et al., 1999) .
Here we show that the injection of human Ps1 mRNA into Xenopus embryos produced changes along the primary neurogenesis cascade that closely resembled the effects of X-shh overexpression. Furthermore, both Ps1 and X-Ps-a increased the amounts of X-shh transcripts, mainly in thē oor plate, and an antisense morpholino oligonucleotide directed against the endogenous X-Ps-a mRNA reduced X-shh expression. In addition, while X-shh overexpression produced a widespread induction of proliferation and apoptosis, Ps1 only promoted these responses within domains of shh signaling. We propose that presenilin may modulate primary neurogenesis, proliferation, and apoptosis by facilitating X-shh expression.
Results

Ps1 disfavors primary neuron formation without impairing neural development
To investigate whether Ps1 is able to modulate primary neurogenesis, we examined the effects of unilateral Ps1 injection on the pattern of N-tubulin at neurula stage. The injected side showed a down-regulation of N-tubulin predominantly in the intermediate and sensory stripes and in the trigeminal ganglion (Fig. 1A) . Several embryos (65%, n 40) revealed a ventral displacement of lateral neurons, perhaps because of an expansion of the neural plate. Therefore, we analyzed the expression of the general neural marker nrp-1 (Knetch et al., 1995) and found that the nrp-1 domain was expanded on the injected side (Fig. 1B) . We conclude that Ps1 can suppress primary neurogenesis, but this effect is not due to the inhibition of neural development.
Ps1 down-regulates Gli3 and promotes Zic2 expression
To analyze which steps of the neurogenesis cascade were modi®ed by Ps1 injection, we examined the distribution of transcripts corresponding to prepattern genes with opposite functions like Gli3 and Zic2 (Brewster et al., 1998) . Ps1-injected embryos showed a down-regulation of Gli3 (Fig.  1C) . Conversely, Zic2 expression was clearly expanded (Fig. 1D) . Taken together, these results suggest that Ps1 reduced primary neuron formation by controlling the balance of prepattern genes with antagonistic actions: while promoting the expression of the negative regulator of neurogenesis Zic2, Ps1 suppressed the positive regulator Gli3.
Retinoic acid (RA) counteracts the effects of Ps1 on primary neuron differentiation
Retinoids have the ability to enhance primary neurogenesis at very early steps, by controlling events upstream of the prepattern genes Gli3 and Zic2 (Franco et al., 1999) . Since Ps1 abolished primary neurogenesis, at least by an opposite control over these prepattern genes, we wanted to analyze the hierarchy of this regulation. Therefore, we considered whether RA treatment could overcome the Ps1-induced suppression of primary neurons. Unilaterally Ps1-injected embryos were treated with RA during gastrulation and the N-tubulin pattern was analyzed at neurula stage. We found that N-tubulin domains were clearly expanded despite Ps1 injection (Fig. 1F) . Therefore, RA rescues the inhibitory effect of Ps1 on primary neuron development, arguing against a retinoid control on Ps1 activity.
Ps1 impairs primary neurogenesis before lateral inhibition takes place
The impairment of primary neurogenesis by Ps1 could be the consequence of enhancing lateral inhibition at the time of primary neurogenesis. However, we found that X-Delta-1 domains were reduced after Ps1 injection (Fig. 1E ). Future primary neurons are the source of X-Delta-1 (Chitnis et al., 1995) and X-Delta-1 is under the positive control of X-ngnr-1 (Ma et al., 1996) . The down-regulation of X-ngnr-1 in Ps1-injected embryos (data not shown) con®rmed that a smaller amount of proneural precursors was produced, and this may account for the reduction of X-Delta-1 expression. Therefore, instead of an enhancement of lateral inhibition, our results favor the hypothesis that Ps1 interferes with the primary neurogenesis cascade before lateral inhibition takes place.
Presenilin increases X-shh expression and expands thē oor plate domain
Because the injection of both X-shh (Franco et al., 1999 ) and Ps1 mRNAs resulted in strikingly similar changes in the expression pattern of genes involved in primary neurogenesis, we examined whether presenilin and shh signaling were linked in the modulation of this process. Embryos injected with 2 ng of Ps1 mRNA showed a signi®cant increase of X-shh transcripts as revealed by quantitative RT-PCR ( Fig. 2A) . Whole-mount in situ hybridization demonstrated that this enhancement was not ectopic but instead, it only affected the normal domain of X-shh in the dorsal midline. This result was reproduced with X-Ps-a injections, indicating a functional conserved mechanism (Fig. 2D ). Cross-sections revealed that amongst dorsal midline structures that normally express X-shh, presenilin injection selectively expanded the¯oor plate domain (compare Fig. 2E,F) .
A loss-of-function approach with antisense morpholino oligos was recently shown to speci®cally prevent b -catenin activity in Xenopus embryos (Heasman et al., 2000) . In order to block the endogenous X-Ps-a transcript an antisense morpholino (X-Ps-a Mo) was designed complementary to the 5 H UTR region of X-Ps-a mRNA, excluding sequences of the open reading frame (ORF). Since the reintroduction of synthetic target mRNA is a rigorous test of speci®city only if the rescuing mRNA lacks the target region of the antisense morpholino (Heasman et al., 2000) , the synthetic X-Ps-a mRNA ful®lls this requirement, because the 5 H UTR was replaced by globin¯anking sequences from the pCDG1 vector. While X-Ps-a Mo substantially reduced X-shh expression (Fig. 2H) , the coinjection with X-Ps-a mRNA speci®cally reverted the phenotype (Fig. 2I) ; in addition, the injection of a standard negative control morpholino did not change shh expression (Fig. 2G ). To further study the effect of X-Ps-a Mo on the expression of X-PS-a, we analyzed neural plate explants extracts by western blot using anti-PSCT, against the 39-residue carboxyl-terminus of human PS1 that shares complete identity to X-Ps-a corresponding sequence (Tsujimura et al., 1997) . Anti-PSCT recognized an 18±20-kDa component, consistent with a carboxyl-terminal fragment (CTF) generated by the normal endoproteolysis of X-Ps-a and b , as described for presenilins in all studied species. This 18±20-kDa band was not detected when preimmune serum was used as a control. Densitometric analysis of western blots revealed signi®cant reduction of X-PS-CTF immunoreactivity to 45% in X-Ps-a Mo-injected embryos Quantitative RT-PCR analysis of X-shh transcripts at stage 14±15. After Ps1 mRNA bilateral injection, Ps1 increased 122% the X-shh/Ef1a ratio (P , 0:001, n 3) (A). Bilateral delivery of 2 ng of the mutant D385A Ps1 mRNA did not signi®cantly increase the X-shh/Ef1a ratio. However, delivery of 4 ng of the mutant Ps1 mRNA increased 85% the X-shh/Ef1a ratio (P , 0:01, n 2) (B). The constitutively expressed Ef1a transcript was used for normalizing results. Expression levels were compared using the t-test; SEMs are indicated by error bars; n, number of independent experiments, each consisting of RNA samples from ten control or injected embryos that were reverse transcribed and then subjected to quantitative PCR analysis by quadruplicate. On the top of each panel is shown the corresponding ethidium bromide-stained agarose gel of one representative determination. C, control embryos. Minus RT (2RT), PCR ampli®cation without reverse transcriptase. (C±I) WMISH for X-shh showing that presenilin is able to modulate Xshh expression. The pale blue staining indicates the location of the nucb-gal tracer. IS, injected side. NIS, non-injected side. Dorsal views of control (C), X-Psa-(D), standard control morpholino oligo-(control Mo) (G), X-Ps-a Mo-(H), and X-Ps-a Mo 1 X-Ps-a-(I) injected embryos, stage 13±14. Cross-sections of control (E) and Ps1-injected (F) embryos, stage 14. Compare arrowheads between (E, F), showing an expanded distribution of X-shh transcripts in the¯oor plate domain. The notochord (n) was unaffected. (J) Western blots of neural plate extracts with anti-PSCT. An 18±20-kDa immunoreactive band consistent with X-PS CTF endoproteolytic product is reduced in X-Ps-a Mo-injected embryos. as compared to controls (Fig. 2J) . Since both Xenopus presenilins share 80% homology within their carboxyl-terminal sequence, the remaining signal in X-Ps-a Mo-injected embryos could be explained by the presence of X-Ps-b whose levels should be unaffected by X-Ps-a Mo injection. These results further support a positive control mechanism for shh expression by presenilin.
2.6. Ps1-enhancement of X-shh expression may not be mediated by g-secretase activity
It has been described for Ps1 that the substitution of the transmembrane aspartate residues 257 and 385 by alanine in either position substantially reduces g-secretase activity on APP processing. In addition, either mutant appears to act as dominant negative with respect to endogenous Ps1 . They preclude the entry of endogenous presenilins into a functional mature high molecular complex (Yu et al., 2000) . Consequently, we considered whether these residues were essential for increasing X-shh transcripts, and we chose the D385A Ps1 mutant for this purpose. First, we injected 2 ng of D385A Ps1 mRNA, but quantitative RT-PCR did not reveal signi®cant differences of X-shh levels between injected and control embryos (Fig. 2B) . Since we did not perceive a dominant negative effect, we considered the possibility that the delivered amount of mutant mRNA was not suf®cient to reduce X-shh expression. However, when 4 ng of D385A Ps1 mRNA were injected, we observed a signi®cant increase of X-shh transcripts (1.7-fold compared to control embryos; Fig. 2B ). It is noteworthy that we had to inject twice the amount of mutant in relation to wild type Ps1 mRNA to obtain a similar increase of X-shh transcripts (1.7-vs. 2.4-fold increase for mutant and wild type Ps1, respectively; compare Fig.  2A,B) . Therefore, Asp 385 does not seem to be essential for modulating X-shh expression, although its substitution reduces the ef®ciency of Ps1 for exerting this activity. Hence, we presume that the g-secretase activity proposed for Ps1 is unlikely modulating X-shh signaling. Alternatively, D385A Ps1 may retain residual g-secretase activity in Xenopus embryos. However, this activity was not reported for this mutant in transfected cell lines .
Ps1 stimulates cell proliferation under the in¯uence of endogenous shh
Nuclear Hoechst staining revealed a higher cell number within the Ps1-injected side (not shown), therefore we considered the possibility that Ps1 was inducing cell proliferation. Thus, we compared the expression of proliferating cell nuclear antigen (PCNA; Waseem and Lane, 1990) between control and Ps1-injected embryos. Western blot analysis of the detergent-soluble fraction revealed that at gastrulation and neurulation, PCNA levels were signi®-cantly higher after Ps1 injection (Fig. 3A) . This result was con®rmed by densitometry of blots from two independent experiments. At gastrulation and neurulation PCNA levels in Ps1-injected embryos were four-fold and seven-fold higher, respectively, than in sibling controls. This result clearly demonstrates that Ps1 has the ability to promote cell proliferation. Likewise, we have previously reported that X-shh-injected embryos had higher cell amounts on the injected side, leading us to propose a proliferative role for X-shh in the neural ectoderm (Franco et al., 1999) . In order to verify this and to compare the distribution of proliferative cells after Ps1 and X-shh mRNA injection, we performed whole-mount inmunolocalization of PCNA at neurula stage in unilaterally injected embryos. Both molecules produced a remarkable induction of proliferation on the injected side (Fig. 3B,C) . It was signi®cant to ®nd out that while X-shh promoted proliferation all over the injected side, Ps1 did it only within and around the dorsal midline (Fig. 3B,K) , where shh signaling is normally operating. These results suggest that the effect of Ps1 on proliferation may be mediated by the increase of X-shh expression in thē oor plate.
Ps1 stimulates programmed cell death in domains of shh signaling
An involvement of presenilins in regulation of apoptosis has been suggested by previous investigations in various cell culture systems (see Section 1). Besides Ps1 ability to promote proliferation, it was conceivable that a decrease of PCD also contributed to raise the cell number after Ps1 injection. Since Ps1 modulation of neural patterning and proliferation may be mediated by shh signaling, we inves- Embryos bilaterally injected with Ps1 or X-shh mRNA show an increased caspase-3 activity at stage 10.5 and at stage 12 (69% for Ps1, n 3; 97% for X-shh, n 3) when compared to controls (Ctrl, n 4). Caspase-3 activity declines at neurula stages (stage 15). Values are expressed as percentage of the activity from control extracts; SEMs are indicated by error bars; n indicates the number of independent caspase-3 determinations, each consisting of extracts from 30 embryos. The observation that at neurulation TUNEL staining revealed strong signal while caspase-3 activity declined is consistent with the fact that caspase-3 activation precedes DNA fragmentation during apoptosis (Liu et al., 1997) . tigated whether Ps1 and X-shh can also affect the apoptotic pattern.
The apoptotic signaling pathway involves the activation of death-speci®c proteases known as caspases. One of them, caspase-3, is a critical mediator responsible for dismantling cellular proteins (Salvesen and Dixit, 1997) . As a quantitative measure of apoptosis, we determined caspase-3 activity at different stages in crude extracts from embryos injected with Ps1 or X-shh mRNA. Both molecules produced a signi®cant increase of caspase-3 activity, stronger at gastrulation (stages 10.5 and 12) than at neurulation (stage 15) (Fig. 3J) . Therefore, we decided to compare the spatial distribution of apoptotic nuclei undergoing DNA fragmentation after Ps1 and X-shh injection. Whole-mount TUNEL revealed that at stage 12 apoptotic cells are normally dispersed around the blastopore (Fig. 3D) , as previously shown (Hensey and Gautier, 1998) . While unilateral injection of Ps1 enhanced apoptosis in a restricted region on the blastopore lip (Fig. 3E ), X-shh produced a widespread and strong induction of apoptotic cells all over the injected side (Fig. 3F) . Such different behaviors were observed again at neurula stages. While some scattered apoptotic cells were evident at stage 15 on the neural plate of control embryos (Fig. 3G) , as previously reported (Hensey and Gautier, 1998) , Ps1 injection resulted in a clear induction of apoptosis in a dorsal midline stripe (Fig. 3H,L) and X-shh injection produced a remarkable induction of apoptosis in large patches on the injected side (Fig. 3I) . Because an inhibition of PCD does not account for the increase in cell number observed after X-shh and Ps1 injection, the induction of apoptosis by these molecules may be the result of a mechanism that counterbalances their proliferative stimulus. It is noteworthy that resembling the effects on proliferation, Xshh was capable of inducing extensive cell death while Ps1-induced apoptosis restricted to the places of normal shh signaling. All these evidences further support the idea that presenilin may regulate different mechanisms that contribute to neural patterning by modulating X-shh expression.
Discussion
Presenilin modulates the balance of prepattern genes and favors the suppression of primary neurons
Several reports suggest that presenilins may participate in neuronal development. Evidences include their abundant expression during periods of neurogenesis (Berezovska et al., 1997; Shen et al., 1997; Mattson et al., 1998) , the loss of neural progenitor cells and neurons from brains of mice lacking Ps1 (Shen et al., 1997) , and the neurogenic phenotypes in Drosophila presenilin loss-of-function mutants . Apart from other studies concerning presenilin facilitation of Notch signaling (De Strooper et al., 1999; Struhl and Greenwald, 1999; Handler et al., 2000) , here, within the frame of the Xenopus primary neurogenesis cascade, we explore the ability of presenilin to regulate different steps of the genetic pathways leading to neuronal differentiation.
We show that injection of Ps1 mRNA in frog embryos produces a substantial suppression of N-tubulin 1 primary neurons. We propose that this effect is decided earlier in the cascade, as evidenced by the opposite changes in the expression of two prepattern genes with antagonistic actions. Hence, Ps1 seems to control neurogenesis at least by increasing the expression of Zic2, a gene proposed to inhibit neuronal differentiation, and by reducing the expression of Gli3, an activator of neuron formation (Brewster et al., 1998) , thus leading to a decrease of proneural domains, as con®rmed by the disorganization of X-ngnr-1 longitudinal stripes. This explains the reduction of X-Delta-1 expression, because X-Delta-1 is under the positive control of X-ngnr-1 (Ma et al., 1996) . Notwithstanding the reported observations that Ps1 is a positive regulator of Notch processing (De Strooper et al., 1999; Struhl and Greenwald, 1999; Ray et al., 1999) , our results indicate that the reduction of primary neurogenesis produced by Ps1 was mainly due to the impairment of events that precede lateral inhibition in the genetic cascade and that this modulation occurs at some level upstream of prepattern genes.
Presenilin positively regulates X-shh expression within the domain of shh signaling
Our results indicate that Ps1 can modulate the expression of prepattern genes in the same way as previously shown for X-shh overexpression (Franco et al., 1999) , suggesting that both molecules share some regulatory pathway above this level in the primary neurogenesis cascade. After Ps1 injection, we found a notorious increase of X-shh transcripts by quantitative RT-PCR. Yet, in situ hybridization revealed no ectopic sites of expression. Instead, both Xenopus and human presenilin expanded the distribution of X-shh transcripts in the¯oor plate domain, and blocking the endogenous X-Ps-a mRNA with an antisense morpholino oligo speci®cally reduced X-shh expression. Thus, we conclude that the presenilin-induced enhancement of X-shh expression cannot occur outside the domains of shh signaling. Taken together, our results indicate that presenilin may modulate the balance of prepattern genes by facilitating Xshh expression in the¯oor plate. Although retinoid signaling down-regulates shh expression (Franco et al., 1999) , it is unlikely that this happens through the negative control of presenilin activity because RA treatment could rescue the inhibitory effect of Ps1 on primary neuron development. Nevertheless, from our results we cannot discern whether presenilins and retinoids are part of two separate pathways with antagonistic functions converging on the control of shh signaling, or if presenilins are able to negatively modulate retinoid signaling, releasing shh from retinoid repression.
3.3. The enhancement of shh signaling by presenilin may be favoring proliferation and apoptosis against primary neuron differentiation
The suggestion of a proliferative role for X-shh in vivo at neural plate stages (Franco et al., 1999) gained support here, because X-shh overexpression promoted strong PCNA immunostaining all over the injected side. This is consistent with previous observations in mice that shh behaves as a mitogen for cultured perinatal neural retinal precursor cells (Jensen and Wallace, 1997) , prevents neuronal differentiation, and induces proliferation of granule cerebellar cell precursors in vitro (Weschler-Reya and Scott, 1999) and also stimulates proliferation and blocks differentiation of spinal cord neural precursor cells at embryonic stages in vivo (Rowitch et al., 1999) . In addition, here we show that X-shh stimulated PCD extensively, perhaps as a mechanism to counterbalance proliferation. We found that Ps1 also favored proliferation and apoptosis, but unlike X-shh overexpression, both effects were restricted within and around the dorsal midline. Therefore, X-shh does not seem to require a located cofactor to modulate proliferation and apoptosis. In contrast, both processes can be regulated by Ps1 only within the range of X-shh signaling. From these evidences we conclude that Ps1 may interact with some factor(s) exclusively present within shh expression domains. The Ps1-induced proliferation pattern correlates in part with the expansion of the expression domain of shh, but also extends at some distance on the neural plate, consistent with the idea that Ps1 enhances the production of a secreted molecule, perhaps Shh protein, which promotes proliferation in neural cells adjacent to the¯oor plate.
In spite of the suppression of primary neurogenesis and the simultaneous activation of cell proliferation in the neural plate, secondary neurogenesis was ®nally stimulated in the ventral neural tube after injection of either X-shh (Franco et al., 1999) or Ps1 (not shown), as revealed by the ventral neural marker Xsal-1 (Hollemann et al., 1996) . This led us to presume that shh signaling could be withdrawing precursor cells from premature differentiation, holding their proliferative state, and reserving them for later waves of neuron formation. Presenilin, through the enhancement of shh signaling, may also contribute to this mechanism. This is consistent with the fact that mice lacking Ps1 undergo premature differentiation of neural progenitor cells into post-mitotic neurons (Handler et al., 2000) .
From all these evidences we propose that presenilin may promote proliferation and apoptosis and suppress primary neurogenesis by facilitating shh signaling.
How can presenilin modulate shh signaling?
The selective expansion of the X-shh expression domain in the¯oor plate resulting from presenilin injection is consistent with the observation that mice lacking both presenilin genes show complete absence of shh transcripts in the trunk ventral neural tube, but expression remains unaltered in the head and notochord (Donoviel et al., 1999) . From these observations we infer that the failed development of Nkx2.2 1 motorneurons in the trunk of these mutants may be due to the absence of shh signaling from the¯oor plate. Because widespread expression of presenilin does not result in ectopic activation of X-shh, we propose that presenilin needs a cofactor spatially restricted to the dorsal midline of the embryo in order to facilitate shh expression in the¯oor plate. During the sequence of events following the presenilin-independent transcription of shh in the notochord until the activation of shh in the¯oor plate, presenilin activity could be interacting at any point. Much research has been focused to establish that hedgehog signaling can be regulated at several steps, during post-translational processing and traf®cking of Hedgehog protein in sending cells, and during reception and signal transduction in the receiving cells (for review, see McMahon, 2000) . In this scenario, presenilins could be facilitating any of these steps, either in the notochord (sending cells), or in the¯oor plate (receiving cells). Both hypotheses can equally explain why the absence of presenilins (Donoviel et al., 1999) as well as the injection of either Ps1 or X-Ps-a mRNAs (this paper) can affect shh expression only in the ventral midline of the central nervous system. Several of the functional features proposed for presenilins may be involved in either of the indicated points of the shh signaling pathway. Amongst them, the g-secretase activity may not be involved, because the substitution of Asp 385, which was shown to suppress such activity , did not abolish the ability of Ps1 to increase X-shh transcripts. Nevertheless, it remains to be tested whether this mutant retains residual g-secretase activity in Xenopus embryos. Other lines of research have proposed that presenilins play a role in traf®cking and metabolism of membrane and secreted proteins in neurons (Naruse et al., 1998) . Furthermore, numerous biochemical interactions have been described between presenilins and a variety of proteins, including members of the b -catenin family, cytoskeleton-and microtubule-associated proteins, calcium-binding proteins, G-proteins, and GTPases (Buxbaum et al., 1998; Murayama et al., 1998; Smine et al., 1998; Takashima et al., 1998; Zhang et al., 1998; Dumanchin et al., 1999; Levesque et al., 1999; Nishimura et al., 1999; Stabler et al., 1999; Noll et al., 2000) .
Regardless of the mechanism underlying the interaction between presenilins and shh signaling, we propose from this body of evidence that the suppression of primary neurogenesis and the stimulation of proliferation and PCD by shh signaling from the¯oor plate may be facilitated by presenilins. Identifying the role of presenilins during shh signaling will provide clues to understand how these important molecules could interact. Finally, it will be interesting to explore whether hedgehog signaling is involved in the pathogenesis of familiar AD.
Experimental procedures
Embryo culture, RNA injections, treatments, and procedures
Albino Xenopus laevis embryos were obtained using standard methods (Stern and Holland, 1992) and staged according to Nieuwkoop and Faber (1994) . At the desired stages, embryos were either ®xed with MEMFA (Harland, 1991) for in situ hybridization analysis, whole-mount TUNEL and immunohistochemistry, or homogeneized for RNA extraction, western blot analysis, or caspase-3 activity determination. The entire X-Ps-a ORF was obtained by RT-PCR from tailbuds RNA, inserted by Exo III mediated subcloning (Li and Evans, 1997) into the pCDG1 vector (Blumberg et al., 1998) that had been digested with Nco I and BamH I. The sequence was 100% identical to the published one (Tsujimura et al., 1997) . Synthetic capped mRNAs for microinjection were obtained by in vitro transcription with the Megascript kit (Ambion), and were puri®ed with the RNeasy mini kit (Qiagen). Two nanograms of human Ps1, X-Ps-a , or X-shh mRNAs or 2 and 4 ng of D385A human Ps1 mRNA were microinjected per embryo. The X-Ps-a antisense oligodeoxynucleotide (X-Ps-a Mo) used was a 25-mer morpholino oligo (Gene Tools, LLC) with the base composition 5 H -GTCAGCGGAATCTTCAGACACTTGG-3 H , and was injected in doses of 5 or 10 ng per embryo. Delivery was done into the animal hemisphere of one or both blastomeres, at the two-cell stage. To test for the speci®city of the phenotype, either 5 ng of a standard control morpholino oligo were injected (5 H -CCTCTTACCTCAGTTACAATTTATA-3 H ) or a rescue experiment was carried out by co-injecting 5 ng of X-Ps-a Mo together with 1 or 2 ng of X-Ps-a mRNA. Injections always included 100 pg of nuc-bgal mRNA as tracer. Embryos were maintained in 6% Ficoll, 1£ Barth-Hepes saline (BHS; Gurdon, 1976 ) until 1 h after injection, and then were cultured in 3% Ficoll, 0.1£ BHS until sibling controls reached the desired stage. Treatments with 10 mM all-trans RA (Sigma) were performed in 0.1£ BHS from stage 9±10 until stage 15. X-gal staining, preparation of digoxigenin-labeled antisense RNA probes, whole-mount in situ hybridization (WMISH) and histological sections in paraplast were performed as previously described (Franco et al., 1999) . For TUNEL and PCNA processed embryos, 50-mm sections were taken in an Oxford Vibratome and mounted onto gelatin-coated slides as described by Hollemann et al. (1996) .
Site-directed mutagenesis
Human wild type Ps1 was used as template to introduce D385A by asymmetric PCR-based site-directed mutagenesis. The following primers were used in the ®rst PCR: forward 5 H -GAAGGATCCACGAGCCGCGGC-3 H and reverse 5 H -AGAAAAGTGAAAGCTCCCAATCCAAG-3 H . The PCR product was puri®ed and used as forward primer in a second reaction with the reverse primer 5 H -TCAGAA-TTCAGTTAATACAGAATTATT-3 H . The resultant mutant was cloned into the vector pcDNA3 (Invitrogen), and the identity was con®rmed by sequencing.
Quantitative RT-PCR
For each experiment, total RNA was isolated at stage 14± 15 from ten embryos, using the SV Total RNA Isolation System (Promega). Two micrograms of total RNA were reverse transcribed with Superscripte II RNase H 2 Reverse Transcriptase (Gibco BRL). PCR was carried out with Taq DNA polymerase (Promega) in 50-ml reactions. Temperature cycles consisted of 94, 60, and 728C steps, 30 s each, with an initial 5-min denaturation step at 948C. Final extension was at 728C, 5 min. Ten microliters of the reaction were analyzed on ethidium bromide-2% agarose gels. Experiments always included non-reverse transcribed RNA samples as negative controls. The number of cycles and the template input for PCR were determined empirically in each case, within the linear range of ampli®cation. The forward (F) and reverse (R) primer sequences, the product sizes, and the number of cycles were as follows:
H , 268 bp, 25 cycles; X-shh:
H , 526 bp, 34 cycles. Each independent experiment was subjected to PCR analysis by quadruplicate. X-shh was normalized to the amount of the constitutively expressed Ef1a transcript. Measurements were done with Sigma Gel software.
Caspase-3 activity
Embryos were washed in PBS and homogeneized in 10 mM Tris±HCl, 10 mM NaH 2 PO 4 /NaHPO 4 pH 7.5, 130 mM NaCl, 1% Triton X-100, 10 mM NaPPi, with a glass Pyrex homogenizer. Homogenates were centrifuged for 10 min at 13 000 £ g at 48C. Caspase-3 activity was determined in the supernatants with the PharMingen-Becton Dickinson caspase-3 assay kit. Fluorescence was normalized against protein concentration.
Whole-mount TUNEL
Whole-mount TUNEL staining was based on the protocol of Hensey and Gautier (1997) , with several modi®cations. Fixed embryos were shortly stored at 48C in PBS. After rinsing in fresh PBS, they were treated for 15 min with 2.5 mg/ml proteinase K (Merck) in PTW (PBS containing 0.2% Tween 20) at room temperature, then re®xed for 30 min with 4% formaldehyde in PBS and washed several times with PBS. Following 1 h preincubation with terminal deoxynucleotidyl transferase (TdT) buffer, reaction with 300 U/ml terminal TdT (GIBCO BRL) proceeded overnight at room temperature in the presence of 1 mM digoxigenindUTP (Boehringer Mannheim) and was stopped by treat-ment for 2 h at 658C in PBS containing 1 mM EDTA. Embryos were extensively washed in PBS, then for 15 min in PBT (PBS containing 2 mg/ml bovine serum albumin and 0.1% Triton X-100), and treated for 1 h with blocking buffer containing 2% Boehringer Mannheim blocking reagent in MAB (100 mM maleic acid, 150 mM NaCl, pH 7.5). After overnight incubation at 48C with antidigoxigenin antibody coupled to alkaline phosphatase (Boehringer Mannheim) diluted 1/2000 in blocking buffer, embryos were extensively washed in PBT at room temperature, followed by an overnight wash at 48C in PBT. Following two short changes of alkaline phosphatase buffer (100 mM Tris±HCl pH 9.5, 50 mM MgCl 2 , 100 mM NaCl, 0.1% Tween 20, 5 mM levamisol), staining was developed at 378C in the same buffer containing 337 mg/ml nitro blue tetrazolium (NBT) and 175 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (BCIP). After washing in methanol, embryos were rehydrated and viewed.
Sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE) and western blots
Embryos were homogenized in 50 mM Tris±HCl pH 8.0, 25% glycerol, 50 mM KCl, 2 mM DTT, 2 mM PMSF, 0.1 mM EDTA, 10 mg/ml aprotinin, and 10 mg/ml leupeptin, and centrifuged at 11 000 rpm at 48C, 8 min. Pellets were resuspended in 150 mM NaCl, 10 mM Tris±HCl pH 7.4, 0.5% NP40, 5 mM EDTA, 2% SDS, 2 mM PMSF, 10 mg/ml leupeptin, 0.1 mg/ml pepstatin, sonicated on ice, and centrifuged as before. Supernatants were mixed with equal volumes of sample buffer containing 8% SDS and 0.1 M DTT, boiled for 3 min, and subjected to electrophoresis on 10% Tris±tricine SDS-PAGE. Proteins were transferred to PVDF membranes and probed with PCNA monoclonal antibody (Santa Cruz Biotechnology, Inc.). After incubation with horseradish peroxidase-labeled secondary antibody (Bio Rad), the reaction was visualized with ECL plus (Amersham-Pharmacia). Densitometry was performed with Gel Pro Analyzer software (Media Cybernetics).
To quantitate the expression of X-Ps-a protein, neural plate explants were solubilized in sample buffer containing 8% SDS. Five explants were loaded per lane in 10% Tris± tricine gels and blotted with anti-PSCT. Immunoreactive bands were developed as above and analyzed with a STORM 840 Imaging system (Molecular Dynamics).
Presenilin antibodies
Polyclonal antibodies were raised in rabbits using glutathione-S-transferase (GST) fused to amino acids 429± 467 of human PS1. The antiserum (anti-PSCT) was sequentially puri®ed using a BL21/GST lysate and the immunogen coupled to CNBr-activated sepharose (Pharmacia) as af®-nity columns, respectively. Speci®city of anti-PSCT was tested against GST and fusion protein by western blot as described previously.
PCNA immunohistochemistry
Fixed embryos were washed twice in PBS and thrice in PBS containing 0.3% Triton X-100, for 15 min each, and left overnight at 48C in blocking buffer. They were incubated for 5 h at room temperature with PCNA antibody diluted 1/50 in blocking buffer, washed twice at room temperature and overnight at 48C with PTW, and thrice with PBS, for 10 min each. Then, they were left for 30 min in blocking buffer and incubated for 5 h at room temperature with anti-mouse antibody coupled to alkaline phosphatase (Promega) diluted 1/500 in blocking buffer. After washing twice for 15 min at room temperature and overnight at 48C with PTW, color reaction was developed at 378C with 337 mg/ml NBT and 175 mg/ml BCIP. Embryos were rinsed in distilled water, washed in methanol, and rehydrated for viewing.
